BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32513225)

  • 1. Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
    Mohamed MMA; El-Shimy IA; Hadi MA
    Crit Care; 2020 Jun; 24(1):311. PubMed ID: 32513225
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
    Courcelle R; Gaudry S; Serck N; Blonz G; Lascarrou JB; Grimaldi D;
    Crit Care; 2020 Jul; 24(1):446. PubMed ID: 32684169
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
    Bendjelid K; Giraud R; Von Düring S
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
    Savioli F; Rocha L; Góis A; Nakano LC
    J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
    [No Abstract]   [Full Text] [Related]  

  • 5. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.
    Faul JL; Kerley CP; Love B; O'Neill E; Cody C; Tormey W; Hutchinson K; Cormican LJ; Burke CM
    Ir Med J; 2020 May; 113(5):84. PubMed ID: 32603575
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 9. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 10. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.
    Garcia B; Cousin N; Bourel C; Jourdain M; Poissy J; Duburcq T;
    Crit Care; 2020 Jul; 24(1):428. PubMed ID: 32665007
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19.
    Kimmoun A; Levy B; Chenuel B;
    Crit Care; 2020 Aug; 24(1):509. PubMed ID: 32811555
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
    Soto M; diZerega G; Rodgers KE
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
    Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
    Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
    Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
    Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
    Matucci-Cerinic M; Bruni C; Allanore Y; Clementi M; Dagna L; Damjanov NS; de Paulis A; Denton CP; Distler O; Fox D; Furst DE; Khanna D; Krieg T; Kuwana M; Lee EB; Li M; Pillai S; Wang Y; Zeng X; Taliani G
    Ann Rheum Dis; 2020 Jun; 79(6):724-726. PubMed ID: 32349982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
    Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
    [No Abstract]   [Full Text] [Related]  

  • 18. Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management.
    Bos LDJ; Paulus F; Vlaar APJ; Beenen LFM; Schultz MJ
    Ann Am Thorac Soc; 2020 Sep; 17(9):1161-1163. PubMed ID: 32396457
    [No Abstract]   [Full Text] [Related]  

  • 19. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
    Kloc M; Ghobrial RM
    Mult Scler Relat Disord; 2020 Oct; 45():102437. PubMed ID: 32763844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the role of rheumatologists in the era of COVID-19?
    Marotto D; Sarzi-Puttini P
    Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.